This Cybersecurity Stock Is Beating the Market in 2025. Is It Still Worth Buying Hand Over Fist?
CrowdStrike stock has the market's attention even though the company is seeing effects from last year's IT outage.
The cybersecurity specialist's valuation is elevated even though its earnings are expected to contract in fiscal 2026.
The good news is that CrowdStrike should see solid earnings growth once again, beginning next year.
10 stocks we like better than CrowdStrike ›
The tech-laden Nasdaq Composite index is up roughly 3% so far this year as stocks in the technology sector come under pressure from macroeconomic and geopolitical factors. However, certain stocks continue to do well despite the broader market's weakness.
Cybersecurity specialist CrowdStrike (NASDAQ: CRWD) posted respectable gains of 44% so far in 2025, far outpacing the tech-laden index. Let's see why that has been the case and check if this cybersecurity stock is still worth buying.
A defective software update from CrowdStrike knocked out global IT systems on July 19 last year. The company faced lawsuits because of the outage, and offered compensation packages to customers in the aftermath of the incident.
One segment of the business still being hit is its customer choice program (CCP), which gives its customers the flexibility to purchase more of its solutions, extend the duration of their contracts, or both. The compensation package offered to clients hit this program's margins, impacting CrowdStrike's revenue and earnings growth. The company's non-GAAP (adjusted) net income in the first quarter of fiscal 2026 (which ended on April 30) fell 8% year over year to $0.73 per share.
On the bright side, analysts expected a bigger decline and were forecasting $0.65 per share in earnings, suggesting that the impact of the compensation package isn't as bad as the market feared. It helps, too, that CrowdStrike delivered respectable year-over-year revenue growth of 20% to $1.1 billion.
CrowdStrike's full-year guidance indicates that CCP will weigh on its growth this year. The midpoint of its adjusted earnings guidance for fiscal 2026 stands at $3.50 per share, lower than the $3.93 per share in earnings that it generated in the previous fiscal year. The company expects its revenue to increase by almost 21% in fiscal 2026 at the midpoint of guidance, which would be slower than the 29% increase it recorded last year. CrowdStrike management estimates that CCP will impact its revenue to the tune of $10 million to $15 million in each of the remaining quarters this year.
However, the good part is that CrowdStrike's earnings growth should accelerate nicely beginning in fiscal 2027.
That won't be surprising, considering that CrowdStrike sees its total addressable market increasing to $250 billion in the next three years from $116 billion last year, driven by new catalysts such as AI. The company is now offering multiple AI-powered cybersecurity tools to customers, such as protecting large language models (LLMs) in collaboration with Nvidia to agentic AI assistants that can speed up the response to cybersecurity incidents.
The revenue generated from sales of AI tools within the cybersecurity space is expected to jump by more than 4x between 2024 and 2030, generating $134 billion in annual revenue at the end of the decade. As a result, it won't be surprising to see an improvement in the adoption of CrowdStrike's cybersecurity modules by its customers, which should drive an improvement in both sales and margins.
The good thing to note here is that CrowdStrike's module adoption rates have improved despite last year's incident. The company said that 48% of its customers were using six or more of its modules, while 32% were using eight or more of its offerings at the end of the previous quarter. Both numbers were up by four percentage points as compared to the year-ago period.
As such, CrowdStrike could indeed clock robust earnings growth going forward and live up to analysts' expectations thanks to the huge addressable opportunity it is sitting on and its focus on product development to capture opportunities presented by catalysts such as AI.
There remains one big problem for investors who are looking to buy this stock now. CrowdStrike stock has shot up 61% since the incident on July 19 last year, which means that investors have been buying this cybersecurity stock despite the drop in its earnings. As a result, the stock is now trades at an expensive 141 times forward earnings. That's well above its five-year average forward earnings multiple of 106 and the tech-laden Nasdaq-100 index's forward earnings multiple of 28 (using the index as a proxy for tech stocks).
So, investors who have missed CrowdStrike's rally in the past year would do well to stay away from the stock right now, considering its expensive valuation and the expected contraction in its bottom line in fiscal 2026. Of course, the company is expected to clock healthy growth from next year, but the stock seems to have gotten ahead of itself.
That's why it would be a good idea to add CrowdStrike to your watchlists and wait for a pullback in its share price so that you can buy it at a relatively attractive valuation to take advantage of the healthy growth that the company is likely to deliver in the long run.
Before you buy stock in CrowdStrike, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and CrowdStrike wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $689,813!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $906,556!*
Now, it's worth noting Stock Advisor's total average return is 809% — a market-crushing outperformance compared to 175% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of June 23, 2025
Harsh Chauhan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends CrowdStrike and Nvidia. The Motley Fool has a disclosure policy.
This Cybersecurity Stock Is Beating the Market in 2025. Is It Still Worth Buying Hand Over Fist? was originally published by The Motley Fool
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
37 minutes ago
- Bloomberg
Fed's Daly Says Muted Tariff Impact May Open Door to Cut in Fall
By Catarina Saraiva and Updated on Save Federal Reserve Bank of San Francisco President Mary Daly said she's seeing increasing evidence that tariffs may not lead to a large or sustained inflation surge, helping bolster the case for a rate cut in the fall. 'My modal outlook has been for some time that we would begin to be able to adjust the rates in the fall, and I haven't really changed that view,' Daly said Thursday in an interview on Bloomberg Television.
Forbes
38 minutes ago
- Forbes
AI Gave The World Infinite Content—Now What?
Tejas Manohar is the cofounder/co-CEO of Hightouch. Just a few years ago, generative AI (GenAI) felt more like a curiosity than a tool. We asked language models to write love letters in the style of tech bros or explain quantum physics to a 5-year-old. Visual platforms responded to prompts like "a dragon in a business suit, pixel art style" or "a Renaissance portrait of a barista." The results, while novel and amusing, were rarely practical for business. That has changed. By the end of 2024, GenAI outputs became sharper, more polished and increasingly indistinguishable from human-created work. In 2025, with tools like GPT-4, Midjourney, Runway and Canva AI becoming widely adopted, content creation is no longer the bottleneck it once was. Soon, marketing teams will be able to generate dozens of creative options in minutes. However, this shift introduces a new problem: With so much content, how do we decide what to use, for whom and when? Most marketers are now using GenAI to create assets. While Salesforce reports that 76% of marketers use AI to generate content, the processes for deploying that content haven't evolved. The typical workflow still involves pasting AI-generated copy into spreadsheets, testing a couple of variants, manually picking a winner and repeating it all. That might work in the short term, but it's not scalable. More importantly, it doesn't improve over time. More content is not the solution unless there's a system to decide which content to use and how. Imagine an orchestra where every musician trained at Juilliard, but there's no conductor. That's what marketing looks like in a GenAI world without decisioning. There's creativity, but no coordination. Marketers today face a flood of assets, but the bigger challenge is figuring out what to send, to which audience and when. These are not creation problems. These are decisioning problems. And we're still trying to solve them using tools and mental models—journey builders, marketing calendars and simple A/B tests—built for a world where content is scarce. Traditional workflows assume that you'll create a handful of subject lines, define a few segments and test some variations. But GenAI doesn't create one or two options—it creates hundreds. Suddenly, you're staring at thousands of possible combinations across messaging, timing, audience and channels. Marketers can't test every option. They can't manually orchestrate every journey, and they certainly can't rely on batch-and-blast methods anymore. A new approach is needed. For many organizations, AI decisioning has become a key part of their AI strategy. This new category of technology sits between content creation and content delivery. It enables marketers to deploy AI agents that make real-time decisions about which content to send to which user. These systems use reinforcement learning (the same type of machine learning behind self-driving cars and streaming recommendation engines) to optimize for business outcomes like conversions, retention or lifetime value. Think of how platforms like Google and Meta Ads operate. You set your goals, upload creative assets and the system optimizes combinations to deliver results. Now imagine that same model applied to email, push, in-app messaging and CRM. That's what AI decisioning aims to achieve, only this time with transparency and control built in. To adopt AI decisioning effectively, companies need to get the basics right first. That means clarifying goals, improving data access and identifying where manual decisions slow things down. Start small by pinpointing bottlenecks in your workflow, whether that's testing content, segmenting audiences or managing channels. Silos are a major hurdle. When teams like marketing, data and product work in isolation, decisioning falls flat. Aligning around shared goals, metrics and timelines helps break down these walls and ensures AI systems have the inputs they need to be effective. The best way to begin is with a focused use case, such as optimizing subject lines or send times. Prove value quickly and then scale. AI decisioning is not about replacing everything at once; it is about creating a system that learns and improves over time. Used together, these technologies form a closed-loop system. GenAI generates content while AI decisioning systems select the right assets for each user based on performance data. As results come in, those insights feed back into the content generation process, allowing both creation and decisioning to improve continuously. GenAI acts as the input layer, creating at scale. AI decisioning functions as the optimization layer, learning what works and when. Combined, they create a flywheel where content fuels decisions and decisions enhance future content. But none of this works without human oversight. Marketers still need to be involved. AI systems must be transparent, auditable and accountable. Teams need to know how decisions are made, what experiments are running and have the ability to approve content and manage risks. In the coming months, content bottlenecks will fade as GenAI becomes even more integrated into daily workflows. But that's only the first step. The true differentiator will be how effectively teams can deploy the content they generate to drive meaningful results. The winners in the next era of marketing won't be the ones who generate the most creative assets. They'll be the ones who build systems that know what to do with them and can adapt in real time. So keep prompting and creating. But remember: the next meaningful shift in marketing won't just come from creation—it will come from smarter decisioning. Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?
Yahoo
39 minutes ago
- Yahoo
Walgreens (NASDAQ:WBA) Exceeds Q2 Expectations
Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) reported Q2 CY2025 results topping the market's revenue expectations , with sales up 7.2% year on year to $38.99 billion. Its non-GAAP profit of $0.38 per share was 11.3% above analysts' consensus estimates. Is now the time to buy Walgreens? Find out in our full research report. "On March 6, 2025, WBA entered into a definitive agreement to be acquired by entities affiliated with Sycamore Partners. The merger is currently expected to close in the third or fourth quarter of calendar year 2025, pending shareholder and regulatory approvals and other conditions to closing. Upon completion of the transaction, WBA common stock will no longer be listed on the Nasdaq Stock Market, and WBA will become a private company." Revenue: $38.99 billion vs analyst estimates of $36.59 billion (7.2% year-on-year growth, 6.5% beat) Adjusted EPS: $0.38 vs analyst estimates of $0.34 (11.3% beat) Operating Margin: 0.1%, in line with the same quarter last year Free Cash Flow Margin: 0.9%, similar to the same quarter last year Market Capitalization: $9.78 billion Primarily offering prescription medicine, health, and beauty products, Walgreens Boots Alliance (NASDAQ:WBA) is a pharmacy chain formed through the 2014 major merger of American company Walgreens and European company Alliance Boots. A company's long-term sales performance is one signal of its overall quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. With $154.6 billion in revenue over the past 12 months, Walgreens is a behemoth in the consumer retail sector and benefits from economies of scale, giving it an edge in distribution. This also enables it to gain more leverage on its fixed costs than smaller competitors and the flexibility to offer lower prices. However, its scale is a double-edged sword because it's harder to find incremental growth when you've penetrated most of the market. To expand meaningfully, Walgreens likely needs to tweak its prices or enter new markets. As you can see below, Walgreens grew its sales at a sluggish 3.8% compounded annual growth rate over the last six years (we compare to 2019 to normalize for COVID-19 impacts). This shows it failed to generate demand in any major way and is a rough starting point for our analysis. This quarter, Walgreens reported year-on-year revenue growth of 7.2%, and its $38.99 billion of revenue exceeded Wall Street's estimates by 6.5%. Looking ahead, sell-side analysts expect revenue to decline by 1.6% over the next 12 months, a deceleration versus the last six years. This projection is underwhelming and indicates its products will see some demand headwinds. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Same-store sales is a key performance indicator used to measure organic growth at brick-and-mortar shops for at least a year. Walgreens has been one of the most successful retailers over the last two years thanks to skyrocketing demand within its existing locations. On average, the company has posted exceptional year-on-year same-store sales growth of 6.7%. Note that Walgreens reports its same-store sales intermittently, so some data points are missing in the chart below. We were impressed by how significantly Walgreens blew past analysts' revenue expectations this quarter. We were also happy its EPS outperformed Wall Street's estimates. No guidance was provided due to the impending acquisition of the company. Zooming out, we think this was a solid quarter. The stock remained flat at $11.40 immediately after reporting. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
